NL-OMON32254
Completed
Not Applicable
eurocognitive and neuroimaging factors explaining differences in drug use in at-risk cannabis users. - explanatory factors of differential drug use
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- middelen afhankelijkheid (cannabis)
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 70
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male or Female, age 18\-25 years, right handed;At\-risk cannabis user group: 10\-30 marijuana use episodes in the previous month and at least 240 marijuana use episodes in the past 2 years.;Control group 1: matched on gender and ethnicity to the cannabis user group with 1\- 50 lifetime marijuana use episodes (Pope et al. 2001\).;Control group 2: matched on gender and ethnicity to the cannabis user group with 0 lifetime marijuana use episodes (Pope et al. 2001\).
Exclusion Criteria
- •Cannabis user group: seeking treatment or a history of treatment.
- •Control group 1: cannabis use during the past year. (This will be verified by urinalysis.)
- •Control group 2: cannabis use or ever used.
- •The following exclusion criteria will be in effect for all groups:
- •Score of more than 10 on the AUDIT screening questionnaire for alcohol related problems (Saunders et al. 1993\).
- •Smoking more than one pack of tobacco cigarettes per day.
- •Current use of prescription or illicit psychoactive drugs other than marijuana.
- •More than 100 lifetime uses of any non\-cannabinoid class of drug of abuse (Kouri et al. 1999; Pope et al. 2001\).
- •Trying to stop alcohol or tobacco use.
- •Unstable medical illness (e.g., hypertension, diabetes, myocardial infarction).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
eurocognitive functioning and brain plasticity in high-grade glioma patients: a magnetoencephalography pilotglioblastoma multiforme (high-grade glioma)NL-OMON23187VU University Medical Center40
Completed
Not Applicable
eurocognitive functioning and brain plasticity in high-grade glioma patients: a magnetoencephalography pilotGlioblastoma multiforme, high grade GliomaCancerGliomaISRCTN73594603Vrije University Medical Centre (VUMC) (The Netherlands)40
Not yet recruiting
Not Applicable
BIO MARKERS OF COGNITIVE FUNCTIONING IN UNAFFECTED FIRST DEGREE RELATIVES OF DEMENTIA PROBANDSHealth Condition 1: F028- Dementia in other diseases classified elsewhereCTRI/2023/03/050966Central Institute of Psychiatry
Recruiting
Not Applicable
eurocognitive endophenotyping: on the intersection of genetic disorders and psychiatryCognitive DisordersDevelopmental disorders1008362410012562NL-OMON38921niversitair Medisch Centrum Sint Radboud60
Recruiting
Not Applicable
europhysiological study of cognitive and adaptive control between young, elderly and Parkinson's patients using the numerical Stroop testG20.9DRKS00023020niversitätsklinik für Neurologie, Evangelisches Krankenhaus Oldenburg90